The Medical Training (Prioritisation) Act 2026: What Every Medicine Applicant Must Know
- Akash Gandhi

- Apr 13
- 12 min read
At TheUKCATPeople, Dr. Akash and our team of practising UK doctors have been closely following the Medical Training (Prioritisation) Act 2026 since it was first introduced as emergency legislation in January 2026. This is one of the most significant structural changes to NHS medical training in over a decade, and as a medicine applicant, you need to understand exactly what it means, why it happened, and how it might come up at your medical school interview.
Brief Overview: The Medical Training (Prioritisation) Act 2026 is a UK law that prioritises graduates from UK and Irish medical schools, and certain other groups, for NHS foundation and speciality training places. It became law on 5 March 2026 after being fast-tracked through Parliament. The Act directly affects what career path awaits you as a UK-trained doctor, makes for compelling interview discussion material, and raises important ethical questions about fairness, NHS workforce planning, and global health responsibility.

What Is the Medical Training (Prioritisation) Act 2026?
The Medical Training (Prioritisation) Act 2026 is a piece of UK legislation that legally requires NHS training posts, both at foundation level and speciality level, to be offered first to a defined "priority group" of applicants before any remaining places are made available to others. It received Royal Assent on 5 March 2026 and applies across all four UK nations.
The Act was introduced by Health Secretary Wes Streeting as emergency legislation, meaning it was fast-tracked through all parliamentary stages in a matter of weeks rather than following the usual multi-year process. The government argued that the urgency of the workforce crisis facing UK-trained doctors demanded immediate action.
In plain terms, if you graduate from a UK medical school, this law means you now sit at the front of the queue for both foundation programme placements and speciality training posts. For applicants currently considering medicine as a career, this shapes the landscape you will enter upon graduation considerably.
Key Takeaway: The Medical Training (Prioritisation) Act 2026 is now law. It legally mandates that UK and Irish medical graduates are given priority access to NHS training posts, marking a major shift in how the medical workforce pipeline operates.
Why Was the IMG Prioritisation Bill Introduced in the First Place?
To understand this Act, you need to understand the crisis that preceded it. Since visa restrictions were lifted in 2020, the number of international medical graduates (IMGs) applying for UK training posts has increased dramatically. In 2025 alone, 15,723 UK-trained doctors and 25,257 overseas-trained doctors were competing for just 12,833 available round 1 and round 2 speciality training posts. By 2026, the total number of applicants had risen to over 47,000 for the same pool of posts.
This meant that thousands of UK medical graduates, who had completed medical school and their foundation years at significant public and personal expense, were being left without speciality training places. Competition ratios for some programmes reached approximately 4:1. The GP speciality training competition ratio reached a record high in 2025.
The government's core argument was one of public investment. Health Secretary Streeting stated publicly that the UK spends over £4 billion every year training medics, and it made little sense for UK graduates to then be left unable to secure training posts.
Additionally, the Act was partly linked to an ongoing dispute between the government and the BMA's resident doctors committee, with emergency legislation forming part of broader negotiations that had included industrial action in December 2025.
Key Takeaway: The Act was a direct response to a genuine workforce crisis. UK-trained doctors were being locked out of speciality training at record levels, and the government used emergency legislation to address the imbalance created by uncapped international applications following the 2020 visa changes.
Who Exactly Is in the Priority Group Under the Act?
This is an important detail for any applicant to understand accurately. The Act does not simply say "UK citizens first." The priority group is more nuanced than headlines suggest.
For the 2026 foundation programme, priority goes to applicants who obtained their medical qualification within the UK, excluding those who spent the majority of their training time outside the UK, Channel Islands, or Isle of Man. The same applies to graduates of Irish medical schools, excluding those who trained predominantly outside Ireland.
For speciality training, the priority group in 2026 includes UK and Irish graduates, graduates from Norway, Iceland, Liechtenstein, and Switzerland (owing to reciprocal professional agreements), doctors who have already completed a UK foundation programme or core training, and those holding certain immigration statuses such as indefinite leave to remain, EU settled status, or British or Irish citizenship.
From 2027 onwards, prioritisation will also apply at the shortlisting and interview stage, not just at the point of making offers, which represents a considerably more significant filter. Future regulations are expected to define "significant NHS experience" as an additional qualifying criterion for IMGs already working in the NHS.
Not being in the priority group does not mean an IMG cannot apply. It means that prioritised applicants are considered first, and only once that group is exhausted are non-prioritised applicants offered places.
Key Takeaway: The priority group is broader than just UK graduates. It includes Irish graduates, certain European nationals under reciprocal agreements, and IMGs who have already embedded themselves in the NHS through foundation or core training. However, IMGs who have not yet worked in the UK and do not hold a qualifying immigration status are not prioritised.
What Are the Main Ethical Tensions This Act Raises?
This is where your interview preparation becomes critical. The Medical Training (Prioritisation) Act is not a straightforward policy. It involves competing ethical principles that examiners may ask you to navigate thoughtfully. You should be prepared to discuss both sides with nuance rather than simply agreeing it is a good or bad thing.
Justice and fairness: The four pillars of medical ethics include justice, which concerns the fair distribution of resources and opportunities. On one hand, it could be argued that it is just to protect the investment made in UK-trained doctors and ensure they have reasonable access to training. On the other hand, IMGs who have already been working in the NHS and contributing to patient care may feel they are being disadvantaged despite building careers here in good faith.
Brain drain from low-income countries: The government's own impact statement acknowledges significant ethical concerns about recruiting doctors from countries with very low numbers of doctors per head of population, particularly low and lower-middle-income countries. In one reading, the Act reduces this ethical harm by reducing the pull factor drawing international doctors away from healthcare systems that need them far more than the UK does.
Discrimination concerns: The government's own impact assessment acknowledges the policy will likely have a disparate impact on applicants of certain ethnicities, nationalities, and religions, given the demographic composition of IMGs versus UK graduates. This raises questions under the Equality Act and human rights legislation, with some commentators drawing parallels to the BAPIO v Secretary of State legal challenge of 2008.
Procedural fairness: Many IMGs had already paid for and sat exams such as PLAB, submitted applications, and made significant life decisions based on rules that applied at the time. Changing those rules mid-cycle raises questions about legitimate expectation.
For a detailed look at how to approach ethics in an interview, our guide on autonomy in medical ethics and non-maleficence is an excellent starting point.
Key Takeaway: The Act raises genuine ethical tensions around justice, global health responsibility, procedural fairness, and indirect discrimination. Being able to articulate multiple perspectives rather than offering a one-sided view is exactly what medical school interviewers are looking for.

What Does This Mean for the NHS and Future Medical Workforce?
The Act does not create new training posts. That is perhaps the most important caveat raised by the BMA and others. The BMA's resident doctors committee chair, Jack Fletcher, warned that while the legislation was a step forward, the total number of training places still falls far short of what is needed. Reducing the competition ratio from roughly 4:1 to approximately 2:1 for speciality training is meaningful progress, but it does not resolve the underlying shortage.
The government has committed to creating 1,000 new speciality training posts in England as a parallel measure, open to applications from April 2026. However, critics, including the BMA, note this does not come close to bridging the gap, given that over 2,000 appointable UK graduates did not receive an offer in the 2025 round 1 alone.
There are also longer-term workforce sustainability questions. The government has stated an ambition to reduce NHS reliance on international recruitment from around 34% of the workforce today to below 10% by 2035. This is an ambitious target that depends on a substantial and sustained increase in domestically trained doctors, which in turn requires expanded medical school places, foundation posts, and speciality training capacity working in alignment.
For applicants, the message is that your career trajectory is more secure than it would have been even a year ago. The path from medical school through foundation and into speciality training is being deliberately reinforced for UK graduates. Understanding the medical training pathway in the UK is an essential context for any interview.
Key Takeaway: The Act improves competition ratios and job prospects for UK graduates but does not resolve the fundamental shortage of training posts. Sustainable workforce planning requires substantially more posts, not just a reordering of who fills the existing ones.
How Has the BMA and Medical Community Responded?
Reactions to the Act have been cautiously welcoming from UK graduates while raising significant concern for the IMG community.
The BMA welcomed the legislation in broad terms, describing it as recognition of the scale of the bottleneck facing UK-trained doctors. However, the BMA's position had consistently been that IMGs already working in the NHS with at least two years of experience should also sit within the priority group. The Act does not go that far for 2026, instead using immigration status as a proxy for NHS experience, a distinction the BMA publicly criticised.
The Royal College of GPs noted that IMGs currently make up over half of all first-year GP trainees, highlighting the practical dependency the NHS still has on international doctors in some specialities. Abruptly reducing that pipeline without a credible domestic replacement carries its own patient safety risks.
The BMA's medical students committee separately welcomed provisions that should reduce the number of placeholder offers, which had left newly qualified doctors without confirmed placements sometimes until close to their start date, causing significant personal and professional uncertainty.
More broadly, the Act sits within a wider shift in NHS policy following the NHS 10 Year Health Plan and the Darzi Review, both of which identified workforce sustainability as a central challenge. Understanding these intersecting policy strands is valuable preparation for your interview.
Key Takeaway: The medical community broadly supports the direction of the Act while raising important reservations about its scope, particularly for experienced IMGs already contributing to the NHS who are not fully protected under the current provisions.
How Is This Likely to Come Up in a Medicine Interview?
This topic is very relevant for the 2026 application cycle. It touches on NHS workforce planning, medical ethics, global health, fairness, and government policy. Interviewers may present it as a role-play scenario, a discussion prompt, or a data interpretation question. You should be able to discuss it calmly, acknowledging complexity without sitting on the fence.
Our medicine interview coaching sessions cover exactly these types of nuanced NHS hot topics in depth, helping you build a structured approach to discussing policy issues without memorising scripted answers. For a broader view of how the NHS is structured and how the workforce fits within it, see our guide on the structure of the NHS.
When this topic appears in your interview, draw on your understanding of the four pillars of medical ethics, consider the perspectives of different stakeholders (UK graduates, IMGs already in the NHS, patients, taxpayers, healthcare systems in sending countries), and always bring your answer back to what matters most: safe, sustainable, and equitable patient care.
Key Takeaway: This Act is a strong candidate for MMI discussion stations and panel interview questions in the 2026 cycle. Prepare a structured, multi-perspective argument rather than a simple pro or con position.
Potential Interview Questions on the Medical Training (Prioritisation) Act 2026
Preparing for your interview means anticipating how this topic could be framed. Below are questions categorised by likelihood. Working through these with an experienced tutor can sharpen your thinking significantly, and our Medicine Ultimate Package covers exactly this kind of current NHS hot topic preparation with doctors who understand the system from the inside.
Potential Questions (Good for learning)
The UK government has introduced legislation to prioritise UK medical graduates for NHS training posts. Do you think this is the right decision?
How would you explain the Medical Training (Prioritisation) Act 2026 to a patient who asks whether there are now fewer international doctors in the NHS?
What are the ethical considerations involved in prioritising UK medical graduates over international doctors who are already working in the NHS?
A fellow medical student argues that the Act is simply discriminatory. How would you respond?
The NHS relies heavily on international medical graduates. What are the risks of reducing that reliance too quickly?
How does the concept of justice in medical ethics apply to debates about NHS workforce planning and training allocation?
LESS LIKELY (Harder) Questions - Good to Know:
The government's own impact statement acknowledges the Act may disproportionately affect applicants of certain ethnicities and religions. How do you reconcile this with the NHS's commitment to equality?
An international doctor with five years of NHS experience is rejected from speciality training in favour of a newly graduated UK doctor with no NHS experience. Is this outcome justifiable?
If the UK reduces its reliance on IMGs, what are the potential consequences for healthcare systems in countries from which those doctors were recruited?
How does the BAPIO v Secretary of State precedent from 2008 inform your view of the legal and ethical dimensions of this Act?
Model Question and Answer
"The government has introduced emergency legislation to prioritise UK medical graduates for NHS training posts. As a prospective medical student, what are your thoughts on this policy?"
Answer: "I think this is a genuinely complex issue with legitimate arguments on multiple sides. The case for the policy is grounded in principles of justice and sustainable workforce planning. The UK does invest very substantially in training its own doctors, and it seems reasonable that those graduates should have a reliable pathway into the profession they have prepared for. From a systemic perspective, building a stable domestic workforce is probably better for long-term NHS resilience than depending heavily on international recruitment, which is affected by global competition and can raise ethical questions about drawing healthcare professionals away from countries with much greater need.
That said, I also think the policy raises real concerns. Many international doctors have already contributed years of service to the NHS, often in roles and locations where it has been difficult to recruit domestically. It seems difficult to reconcile the NHS's stated values around fairness and inclusion with a system that may disadvantage those doctors after they have already built careers here. I would want to understand more about how significant NHS experience will be defined in future regulations, and whether that can be implemented in a way that genuinely protects doctors who have made long-term commitments to the NHS.
If I were asked for a view overall, I think the direction of the policy is understandable, but the details of implementation will matter enormously. The real solution is probably not just reordering who gets the existing training posts, but ensuring there are enough posts for both domestically trained and experienced internationally trained doctors to have a fair pathway forward."
Frequently Asked Questions About the Medical Training (Prioritisation) Act 2026
What is the Medical Training (Prioritisation) Act 2026?
It is a UK law that gives priority access to NHS foundation and speciality training posts to graduates of UK and Irish medical schools and certain other groups, including doctors already embedded in the NHS. It received Royal Assent on 5 March 2026 after being fast-tracked through Parliament.
When does the Act come into effect?
Prioritisation applies at the offer stage for speciality training posts beginning in August 2026. From 2027, it will also apply at the shortlisting and interview stage, which represents a more significant change to the recruitment process.
Does the Act ban international medical graduates from applying?
No. IMGs can still apply for NHS training posts. However, prioritised applicants are considered first, and non-prioritised applicants are only offered places if there are remaining vacancies once the priority group has been served.
Who counts as a priority applicant?
The priority group includes UK and Irish medical graduates, graduates from Norway, Iceland, Liechtenstein, and Switzerland, doctors who have completed UK foundation or core training, and those holding indefinite leave to remain, EU settled status, or British or Irish citizenship.
Why was the Act fast-tracked through Parliament?
The government argued that the recruitment crisis facing UK-trained doctors was urgent enough to justify emergency legislation, partly to ensure the new rules could apply to the 2026 application cycle already underway. There were also political pressures linked to the resident doctors' industrial dispute.
Does this Act create new training posts?
No. The Act reorders priority for existing posts. The government has separately committed to creating 1,000 new speciality training posts in England, though critics argue this falls far short of what is needed to address the underlying shortage.
What did the BMA say about the Act?
The BMA cautiously welcomed the legislation but expressed concern that it does not go far enough to protect IMGs already working in the NHS with significant experience. The BMA had advocated for all IMGs with two or more years of NHS practice to be included in the priority group.
How does this connect to the NHS 10 Year Health Plan?
The Act implements a specific commitment made in the 10 Year Health Plan published in July 2025, which pledged to prioritise domestically trained doctors for NHS training posts and reduce NHS reliance on international recruitment from around 34% of the workforce to below 10% by 2035.
Will this affect me as a medical school applicant?
As a prospective UK medical student, this Act means your long-term career pathway is more protected than it was previously. Upon graduation, you will be in the priority group for both foundation programme allocation and speciality training applications.
How should I approach this topic in a medical interview?
Approach it as a nuanced ethical and policy question, not a simple yes or no issue. Draw on the four pillars of medical ethics, consider multiple stakeholder perspectives, including UK graduates, IMGs, patients, and sending countries' healthcare systems, and avoid being dogmatic in either direction. Our medicine interview coaching sessions work through exactly this type of current NHS hot topic.
This article reflects information available as of April 2026. The full details of how "significant NHS experience" will be defined for 2027 prioritisation regulations had not yet been confirmed at the time of writing. Individual circumstances vary; applicants should check the NHS England recruitment pages and the BMA's guidance directly for the most current information.













I focused first on educational materials to understand what Klotho is, potential benefits, and limitations. Then I discussed it with my licensed healthcare provider to see how it applies to my health. Because results vary and some therapies are still experimental, nothing can be guaranteed. The site https://ways2well.com/blog/how-to-increase-klotho-naturally-with-klotho-protein-foods was great for clear, structured explanations and helped me think of questions for my doctor.